CYP2C19 and coronary artery disorder: However, for a specific group of people with hypertension, there is currently no systematic conclusion regarding how the polymorphisms of the CYP2C19 gene increase the risk of CAD by influencing metabolic pathways, inflammatory responses, or vascular remodeling [21, 22].